Trial · NCT02059291
Participant flow225
How many started, completed or left each group, period by period.
1 to 20 of 225
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Epoch 2 | STARTED | Epoch 2: crFMF: 150 mg | 31 | |
| Epoch 2 | STARTED | Epoch 2: crCMF: Placebo | 32 | |
| Epoch 2 | STARTED | Epoch 2: HIDS/MKD: 150 mg | 37 | |
| Epoch 2 | STARTED | Epoch 2: HIDS/MKD: Placebo | 35 | |
| Epoch 2 | STARTED | Epoch 2: TRAPS: 150 mg | 22 | |
| Epoch 2 | STARTED | Epoch 2: TRAPS: Placebo | 24 | |
| Epoch 2 | STARTED | Epoch 2: Non-randomized Open Label Treatment - crFMF | 2 | |
| Epoch 2 | STARTED | Epoch 2: Non-randomized Open Label HIDS/MKD | 2 | |
| Epoch 2 | STARTED | Epoch 2 (Epoch 3) - Non-randomized Open Label TRAPS | 18 | |
| Epoch 2 | STARTED | Epoch 3: crFMF Re-randomized From Epoch 2 - 150 mg | 0 | |
| Epoch 2 | STARTED | Epoch 3: crFMF Re-randomized From Epoch 2 - Placebo | 0 | |
| Epoch 2 | STARTED | Epoch 3: HIDs/MKD Re-randomized From Epoch 2 - 150 mg | 0 | |
| Epoch 2 | STARTED | Epoch 3: HIDS/MKD Re-randomized From Epoch 2 - Placebo | 0 | |
| Epoch 2 | STARTED | Epoch 3: TRAPS Re-randomized From Epoch 2 - 150 mg | 0 | |
| Epoch 2 | STARTED | Epoch 3: TRAPS Re-randomized From Epoch 2 - Placebo | 0 | |
| Epoch 2 | STARTED | Epoch 3: crFMF, HIDS/MKD, TRAPS - Not Re-randomized | 0 | |
| Epoch 2 | STARTED | Epoch 4: crFMF - Open Label Cumulative Dose <2700 mg | 0 | |
| Epoch 2 | STARTED | Epoch 4: crFMF - Open Label Cumulative Dose 2700 mg - <5400 mg | 0 | |
| Epoch 2 | STARTED | Epoch 4: crFMF - Open Label Cumulative Dose >=5400 mg | 0 | |
| Epoch 2 | STARTED | Epoch 4: HIDS/MKD - Open Label Cumulative Dose <2700 mg | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02059291/flow